Skip to main content
. 2021 Aug 13;22(16):8726. doi: 10.3390/ijms22168726

Table 3.

Ciguatoxins treatment in different experimental models.

Experimental
Model
Ciguatoxins Exposure Protocol Molecular Target effects Reference
SH-SY5Y 25 pM–100 nM P-CTX-3C short-(4–24 h) and long-term exposure (10 days) cytotoxic effect, alterations of the mitochondrial metabolism,
cell morphology, and [Ca2+]i
[91]
primary cortical neurons 5 nM CTX3C 6-24-
72 h
gene expression alteration mediated by voltage-gated sodium channel [90]
C57BL/6
mice
shallow intraplantar (i.pl.) injection of P-CTX-1 (1–10 nM) Nav 1.8 and TTXs Nav subtypes are effectors of ciguatoxin-induced cold allodynia spontaneous pain [93]
transgenic mice and rat 0.01–31 nM P-CTX-1 (>95% purity) isolated from moray eel (Gymnothorax javanicus) liver NaV1.9 release of calcitonin-gene related peptide (CGRP) from nerve
terminals
[85]
C57BL/6
mice
(0.26 ng/g body weight) intraperitoneally on day 0 followed by second exposure on day 3 P-CTX-1 (isolated and purified from moray eels) irreversible motor deficit in 4-month pre-exposed mice following peripheral nerve injury
astrogliosis and excitotoxic neuronal cell death via the activation of caspase 3 in motor cortex
[94]